Evidence map›Paper›PMID 39480923›Full record

ArticleScience (New York, N.Y.)2024

Group 2 innate lymphoid cells promote inhibitory synapse development and social behavior.

Jerika J Barron, Nicholas M Mroz, Sunrae E Taloma, Madelene W Dahlgren, Jorge F Ortiz-Carpena, Matthew G Keefe, Caroline C Escoubas, Leah C Dorman, Ilia D Vainchtein, Pailin Chiaranunt and 5 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jerika J BarronDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-8983-3126
Nicholas M MrozBiomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-4781-8518
Sunrae E TalomaNeuroscience Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-7210-8614
Madelene W DahlgrenDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-8640-0157
Jorge F Ortiz-CarpenaDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-7727-9674
Matthew G KeefeDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-2477-2975
Caroline C EscoubasDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Leah C DormanDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-5511-887X
Ilia D VainchteinDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-3190-8524
Pailin ChiaranuntDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-8753-1469
Maya E KotasDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-8102-6346
Tomasz J NowakowskiDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-2345-4964
Kevin J BenderKavli Institute for Fundamental Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-7084-1532
Ari B MolofskyDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-0764-3175
Anna V MolofskyDepartment of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-4709-2411

Funding

Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STOCK, PETER G · 2003 to 2019
$21.8M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
Predoctoral Training in NeurobiologyT32NS115706 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SAMUEL JEREMY PLEASURE · 2020 to 2026
$3.4M
Microglial remodeling of the extracellular matrix in memory circuitsR01MH125000 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOLOFSKY, ANNA V · 2021 to 2025
$3.3M
Directed Evolution of Novel AAVs and Regulatory Elements for Selective Microglial Gene ExpressionR01NS126397 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Tomasz Nowakowski, DAVID V SCHAFFER · 2023 to 2026
$3.2M
Localization and function of tissue type 2 lymphocytes during mixed inflammationR01AI162806 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Ari B Molofsky · 2022 to 2026
$2.8M
Defining group 2 innate lymphoid cell lung nichesR01HL142701 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOLOFSKY, ARI B · 2019 to 2022
$2.5M
Meningeal type 2 immunity in cortical synapse remodeling during brain development and injuryR01NS126765 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Anna V Molofsky, Ari B Molofsky · 2022 to 2026
$2.3M
Distinct early and late programs of fibroblast - immune crosstalk govern functional responses to brain injuryR01AI180438 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Ari B Molofsky · 2024 to 2026
$2.3M
Developmental Timing During Cortical DevelopmentR01NS123263 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Tomasz Nowakowski · 2022 to 2026
$2.1M
The function of SCN2A in neocortexR01MH125978 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BENDER, KEVIN J · 2021 to 2025
$2.0M
NHLBI NIH HHS K08 HL155490NHLBI NIH HHS R01 HL142701NIAID NIH HHS R01 AI162806NIAID NIH HHS R01 AI180438NIAID NIH HHS T32 AI007334NICHD NIH HHS T32 HD007470NIDDK NIH HHS P30 DK063720NIH HHS S10 OD021822NIMH NIH HHS F31 MH122207NIMH NIH HHS R01 MH125000NIMH NIH HHS R01 MH125978NINDS NIH HHS R01 NS123263NINDS NIH HHS R01 NS126397NINDS NIH HHS R01 NS126765NINDS NIH HHS T32 NS115706
6 · The paper itself

Abstract

The innate immune system shapes brain development and is implicated in neurodevelopmental diseases. It is critical to define the relevant immune cells and signals and their impact on brain circuits. In this work, we found that group 2 innate lymphoid cells (ILC2s) and their cytokine interleukin-13 (IL-13) signaled directly to inhibitory interneurons to increase inhibitory synapse density in the developing mouse brain. ILC2s expanded and produced IL-13 in the developing brain meninges. Loss of ILC2s or IL-13 signaling to interneurons decreased inhibitory, but not excitatory, cortical synapses. Conversely, ILC2s and IL-13 were sufficient to increase inhibitory synapses. Loss of this signaling pathway led to selective impairments in social interaction. These data define a type 2 neuroimmune circuit in early life that shapes inhibitory synapse development and behavior.

Indexed as

BrainImmunity, InnateInterleukin-13InterneuronsLymphocytesMeningesSocial BehaviorSynapsesAnimalsFemaleMiceMice, Inbred C57BLNeurodevelopmental DisordersSignal TransductionInterleukin-13

Identifiers

PMID39480923
PMCPMC11995778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.